Form 4: Daxor Corp CEO Michael Feldschuh Acquires 45,000 Shares Through Vesting

Daxor Corp's CEO, Michael Feldschuh, acquired 45,000 shares of common stock through vesting on December 6, 2024.

Summary

• Michael Feldschuh, CEO of Daxor Corp, acquired 45,000 shares of Daxor common stock.
• The acquisition occurred through the vesting of previously granted shares.
• The vesting date was December 6, 2024.
• Following the transaction, Mr. Feldschuh directly owns 207,492 shares of Daxor common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The vesting of shares is a routine event, but it does indicate the CEO's continued stake in the company's performance.

Positives

• The vesting of shares indicates a long-term commitment by the CEO to the company's success.
• The increase in share ownership aligns the CEO's interests with those of other shareholders.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders when they acquire or dispose of company stock. It is a routine disclosure and does not indicate any unusual activity.

Comparison to Industry Standards

• This type of transaction is common among publicly traded companies, where executives often receive stock-based compensation that vests over time.
• The reporting of this transaction is in line with SEC regulations for insider trading and transparency.
• Similar filings are made by executives at comparable companies such as Masimo, Edwards Lifesciences, and Medtronic when they receive or sell company stock.

Stakeholder Impact

• The increase in the CEO's share ownership may be viewed positively by shareholders, as it aligns his interests with theirs.

Key Dates

Keywords

Daxor, Michael Feldschuh, share acquisition, vesting, common stock, CEO, insider trading